Rocket Pharmaceuticals (RCKT) Amortizatization of Intangibles (2016 - 2026)

Rocket Pharmaceuticals (RCKT) has 10 years of Amortizatization of Intangibles data on file, last reported at $1.2 million in Q1 2026.

• For the quarter ending Q1 2026, Amortizatization of Intangibles fell 43.88% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $6.3 million (down 15.58% YoY), and the FY2025 full-year result was $7.3 million, down 9.67% from the prior year.
• Amortizatization of Intangibles grew to $1.2 million in Q1 2026, from $1.2 million in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $3.3 million in Q4 2023 to a low of -$577000.0 in Q1 2022.
• A 5-year average of $1.6 million and a median of $1.8 million in 2024 frame the typical range for Amortizatization of Intangibles.
• Across the five-year window, Amortizatization of Intangibles surged 1560.9% in 2023 and tumbled 62.66% in 2024, its largest moves.
• Tracing RCKT's Amortizatization of Intangibles over 5 years: stood at $1.1 million in 2022, then jumped by 202.96% to $3.3 million in 2023, then plunged by 62.66% to $1.2 million in 2024, then declined by 1.23% to $1.2 million in 2025, then climbed by 1.74% to $1.2 million in 2026.
• Business Quant data shows RCKT's Amortizatization of Intangibles at $1.2 million in Q1 2026, $1.2 million in Q4 2025, and $1.7 million in Q3 2025.